Cargando…

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †

Objective: We explored a novel model based on deep learning radiomics (DLR) to differentiate Alzheimer’s disease (AD) patients, mild cognitive impairment (MCI) patients and normal control (NC) subjects. This model was validated in an exploratory study using tau positron emission tomography (tau-PET)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yan, Zhang, Jieming, Chen, Yue, Jiang, Jiehui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406185/ https://www.ncbi.nlm.nih.gov/pubmed/36009130 http://dx.doi.org/10.3390/brainsci12081067

Ejemplares similares

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
por: Ye, Jieping, et al.
Publicado: (2012)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

Imago Mundi, Imago AD, Imago ADNI
por: Villemagne, Victor L, et al.
Publicado: (2014)

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study
por: Bullich, Santiago, et al.
Publicado: (2022)

Using Deep Learning Radiomics to Distinguish Cognitively Normal Adults at Risk of Alzheimer’s Disease From Normal Control: An Exploratory Study Based on Structural MRI
por: Jiang, Jiehui, et al.
Publicado: (2022)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR
por: Goubran, Maged, et al.
Publicado: (2015)

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

Correction to: Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
por: Chen, Dandan, et al.
Publicado: (2023)

Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI
por: Carlson, Mackenzie L., et al.
Publicado: (2020)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
por: Toledo, Jon B., et al.
Publicado: (2013)

Exploratory analysis of radiomic as prognostic biomarkers in (18)F-FDG PET/CT scan in uterine cervical cancer
por: de Alencar, Nadja Rolim Gonçalves, et al.
Publicado: (2022)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Hypoperfusion Precedes Tau Deposition in the Entorhinal Cortex: A Retrospective Evaluation of ADNI-2 Data
por: Kapadia, Anish, et al.
Publicado: (2023)

Combining PET with MRI to improve predictions of progression from mild cognitive impairment to Alzheimer’s disease: an exploratory radiomic analysis study
por: Yang, Fan, et al.
Publicado: (2022)

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau
por: Dickerson, Bradford C., et al.
Publicado: (2013)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Mild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid(®) Treatment on Cognition and (18)F-FDG PET Scans
por: Manzano Palomo, Maria Sagrario, et al.
Publicado: (2019)

Novel ThickNet features for the discrimination of amnestic MCI subtypes
por: Raamana, Pradeep Reddy, et al.
Publicado: (2014)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

The added value of PSMA PET/MR radiomics for prostate cancer staging
por: Solari, Esteban Lucas, et al.
Publicado: (2021)

An Exploratory Study to Detect Ménière’s Disease in Conventional MRI Scans Using Radiomics
por: van den Burg, E. L., et al.
Publicado: (2016)

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018)

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
por: Cong, Wang, et al.
Publicado: (2017)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

Brain signatures based on structural MRI: Classification for MCI, PMCI, and AD
por: Gonuguntla, Venkateswarlu, et al.
Publicado: (2022)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Development and validation of language and visuospatial composite scores in ADNI
por: Choi, Seo‐Eun, et al.
Publicado: (2020)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Multi-Task Linear Programming Discriminant Analysis for the Identification of Progressive MCI Individuals
por: Yu, Guan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g9d99k9vnbgtscq5sfml0b0rbr